|
Video: What is a Stock Split?
|
|
Sigilon Therapeutics is a clinical stage biotechnology company developing a class of therapeutics and functional cures for patients with chronic diseases. Co.'s product candidates include: SIG-005, which treats the non-neurological manifestations of mucopolysaccharidosis type 1 in patients with the disease; SIG-007, which provides continuous and prolonged release of functional enzyme at levels sufficient to produce clinical benefits and alleviate progression of the downstream aspects of Fabry disease; SIG-002, which is designed to replace islet cells for the treatment of Type 1 Diabetes; and SIG-001, which prevents bleeding episodes in patients with moderate to severe Hemophilia A. According to our SGTX split history records, SGTX has had 1 split. | |
|
SGTX (SGTX) has 1 split in our SGTX split history database. The split for SGTX took place on May 23, 2023. This was a 1 for 13 reverse split, meaning for each 13 shares of SGTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 76.9230769230769 share position following the split.
When a company such as SGTX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SGTX split history from start to finish, an original position size of 1000 shares would have turned into 76.9230769230769 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SGTX shares, starting with a $10,000 purchase of SGTX, presented on a split-history-adjusted basis factoring in the complete SGTX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/07/2020 |
|
End date: |
08/11/2023 |
|
Start price/share: |
$397.80 |
|
End price/share: |
$22.47 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.35% |
|
Average Annual Total Return: |
-65.86% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$564.88 |
|
Years: |
2.67 |
|
|
|
Date |
Ratio |
05/23/2023 | 1 for 13 |
|
|